Ollin Biosciences

Ollin Bio

This biotechnology company develops bispecific antibody therapies for patients with vision-threatening conditions such as macular degeneration and thyroid eye disease.

EyeBio

This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.

Eyebiotech Limited

This clinical-stage biotechnology company develops therapies for retinal diseases, such as diabetic macular edema and age-related macular degeneration, to protect and restore patient vision.

Oculis

This biopharmaceutical company develops topical therapies and delivery systems to treat neuro-ophthalmic and ophthalmic diseases for patients with unmet medical needs.

ONL Therapeutics

This biopharmaceutical company develops neuroprotective peptide therapies to prevent retinal cell death and preserve vision for patients with retinal diseases and conditions.

Beacon Therapeutics

This company develops ophthalmic gene therapies to restore vision for patients with rare and prevalent retinal diseases causing blindness.

Iveric Bio

This biopharmaceutical company develops therapeutic treatments for retinal diseases and provides these medicines to patients with age-related macular degeneration and inherited conditions.

Memento Medicines

This biotech company develops biologic therapies for retinal diseases to treat patients with neovascular age-related macular degeneration and diabetic macular edema.